Phase I trial of LCT-Siro (sirolimus)

Trial Profile

Phase I trial of LCT-Siro (sirolimus)

Not stated
Phase of Trial: Phase I

Latest Information Update: 11 Mar 2013

At a glance

  • Drugs Sirolimus (Primary)
  • Indications Coronary artery restenosis; Polycystic kidney disease; Renal transplant rejection
  • Focus Adverse reactions
  • Sponsors Veloxis Pharmaceuticals
  • Most Recent Events

    • 04 Dec 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top